Maravai LifeSciences Holdings, Inc. with ticker code (MRVI) now have 11 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target price High/Low ranges between 27 and 13 calculating the average target price we see $19.18. Given that the stocks previous close was at $13.38 this indicates there is a potential upside of 43.3%. The day 50 moving average is $13.83 and the 200 moving average now moves to $16.61. The company has a market cap of 3.41B. The stock price is currently at: 13.6 USD
The potential market cap would be $4,893,005,912 based on the market consensus.
USD
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 11.53, revenue per share of 5.45 and a 11.55% return on assets.
